共 50 条
- [31] In Vitro Characterization of Vilazodone as a Dual-Acting Serotonin Reuptake Inhibitor and 5-HT1A Receptor Partial AgonistBIOLOGICAL PSYCHIATRY, 2010, 67 (09) : 237S - 237SKehne, John H.Bartoszyk, Gerd D.Greiner, Hartmut E.Pierz, Kerri A.Renda, Matthew J.van Amsterdam, ChristophReed, Carol R.Athanasiou, Maria C.
- [32] Partial Agonist and Biased Signaling Properties of the Synthetic Enantiomers J113863/UCB35625 at Chemokine Receptors CCR2 and CCR5JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (02) : 575 - 584Corbisier, JennyHuszagh, AlexandreGales, CelineParmentier, MarcSpringael, Jean-Yves
- [33] In vitro pharmacological characterization and pro-cognitive effects of the novel alpha-7 nicotinic acetylcholine receptor partial agonist, SKL-A4RBIOCHEMICAL PHARMACOLOGY, 2011, 82 (08) : 1040 - 1040Maeng, C. Y.Joung, C. M.Shin, H. W.Jang, Y. K.Cha, S. B.Cha, H. R.Yi, E. J.Park, C. H.
- [34] A cell-based reporter assay for screening for EcR agonist/antagonist activity of natural ecdysteroids in Lepidoptera (Bm5) and Diptera (S2) cell cultures, followed by modeling of ecdysteroid-EcR interactions and normal mode analysisPESTICIDE BIOCHEMISTRY AND PHYSIOLOGY, 2013, 107 (03) : 309 - 320Zotti, Moises J.De Geyter, EllenSwevers, LucBraz, Antonio S. K.Scott, Luis P. B.Rouge, PierreColl, JosepGrutzmacher, Anderson D.Lenardao, Eder J.Smagghe, Guy
- [35] Partial agonist activity of aripiprazole at D2 and 5-HT1A receptors: Evidence from in vitro binding studiesSCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 155 - 155Jordan, STadori, YMcQuade, RYocca, FKikuchi, T
- [36] The partial dopamine agonist and full serotonin (5-HT)1A agonist pardoprunox (SLV308) has antidepressant and anxiolytie-like properties in rats, a detailed pharmacological evaluationMOVEMENT DISORDERS, 2009, 24 : S224 - S225Ashby, C. R., Jr.McCreary, A. C.
- [37] SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF A NEW CLASS OF 2-OXO-8-AZASPIRO (4,5)DECAN-1-ONES AS ANALOGS OF THE MUSCARINIC AGONIST RS-86FARMACO, 1993, 48 (10): : 1439 - 1445CIGNARELLA, GVILLA, SBARLOCCO, D
- [38] Usmarapride (SUVN-D4010), a 5-HT4 receptor partial agonist for the potential treatment of Alzheimer?s disease: Behavioural, neurochemical and pharmacological profilingEUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 947Nirogi, RamakrishnaGrandhi, Venkata RamalingayyaMedapati, RajeshbabuGanuga, NarenderAbraham, RennyThentu, Jagadeesh BabuPalacharla, Veera Raghava ChowdaryPetlu, SurendraSrirangavaram, MaheshwariSubramanian, RamkumarRavella, Srinivasa RaoGagginapally, Shankar ReddyBenade, VijayJayarajan, PradeepMohammed, Abdul Rasheed
- [39] In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like propertiesNEUROPHARMACOLOGY, 2006, 51 (01) : 129 - 140Zazpe, ArturoArtaiz, InesInnerarity, Anadel Olmo, ElenaCastro, ElenaLabeaga, LuisPazos, AngelOrjales, Aurelio
- [40] The 5-HT4 receptor partial agonist, tegaserod, inhibits the colorectal distension-induced response of rat inferior splanchnic afferents in vitroGASTROENTEROLOGY, 2002, 122 (04) : A317 - A318Wei, JYWang, YHMayer, E